Sign in

CIK 0001595097

  • Non-accelerated filer
  • Smaller reporting company

Corbus Pharmaceuticals Holdings, Inc.

Sign in to watch
Ticker
CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464348039
Phone
+1 617-963-0103
Business address
500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
Former names
SAV Acquisition Corp
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market sale 10% owner sold 30,000 shares at $2.82 ($84,600)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market buy Chief Executive Officer bought 900 shares at $3.28 ($2,952)
  5. 4 Open-market buy Chief Medical Officer bought 2,250 shares at $3.25 ($7,313)
  6. 4 Exercise or conversion Director acquired 60,000 shares (option exercise)
  7. 4 Open-market buy Chief Medical Officer bought 6,000 shares at $3.00 ($18,000)
  8. 4 Open-market buy Director bought 20,000 shares at $3.10 ($62,000)
  9. 4 Open-market buy Chief Financial Officer bought 6,500 shares at $3.00 ($19,500)
  10. 5 Insider Annual Insider Trading Report
  11. 4 Open-market buy Chief Financial Officer bought 18,800 shares at $3.36 ($63,168)
  12. 4 Open-market buy Chief Financial Officer bought 2,850 shares at an average $3.46 ($9,875)
  13. 4 Open-market buy Chief Executive Officer bought 400 shares at $3.66 ($1,464)
  14. 4 Open-market buy Chief Financial Officer bought 1,000 shares at $3.98 ($3,980)
  15. 4 Open-market buy Chief Financial Officer bought 1,700 shares at an average $3.98 ($6,764)
  16. 4 Open-market buy Chief Medical Officer bought 3,300 shares at $3.00 ($9,900)
  17. 4 Open-market buy Director bought 5,000 shares at $3.00 ($15,000)
  18. 4 Open-market buy Chief Executive Officer bought 500 shares at $3.30 ($1,650)
  19. 4 Open-market buy Director bought 1,300 shares at $3.05 ($3,965)
  20. 4 Open-market buy Chief Financial Officer bought 2,000 shares at an average $3.20 ($6,400)

Page 16 of 17 · 340 filings